Clinical Trials Browser

Withdrawn × Interventional × COVID-19 × Clear all

NCT04953312 2026-03-12

CALPRO

Phase NA Withdrawn

MyeloidOther hematologic neoplasm

COVID-19, Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

NCT04575064 2024-10-09

An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANY

Phase 2/3 Withdrawn

COVID-19, Lymphoma, Follicular

NCT05465876 2024-04-04

PACE-CLL

Phase 2 Withdrawn

LymphoidOther hematologic neoplasm

COVID-19, Leukemia, Lymphocytic, Chronic, B-Cell

NCT05125562 2024-02-13

Extracellular Vesicles Infusion Treatment for Mild-to-Moderate COVID-19

Phase 2 Withdrawn

COVID-19, Lymphoma, Follicular

NCT05393999 2023-04-24

SABRE

Phase 2 Withdrawn

LymphoidOther hematologic neoplasmPlasma cell

COVID-19, Leukemia, Lymphoma, Purpura, Thrombotic Thrombocytopenic, Purpura, Thrombocytopenic, Idiopathic, Neoplasms, Plasma Cell

NCT05371275 2022-11-07

CDK6COV

Phase 2 Withdrawn

COVID-19, Lymphoma, Follicular

NCT04392128 2020-09-04

HYACINTHE

Phase 2 Withdrawn

Other hematologic neoplasm

COVID-19, Hematologic Neoplasms

NCT04361552 2020-06-18

Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)

Phase 3 Withdrawn

COVID-19, Coronary Artery Disease, Diabetes Mellitus, Kidney Failure, Chronic, Neoplasms, Stroke, Pulmonary Disease, Chronic Obstructive